Dover Advisors LLC Reduces Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Dover Advisors LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 26.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 3,876 shares of the healthcare conglomerate’s stock after selling 1,411 shares during the quarter. UnitedHealth Group comprises 2.7% of Dover Advisors LLC’s investment portfolio, making the stock its 5th largest holding. Dover Advisors LLC’s holdings in UnitedHealth Group were worth $2,041,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the company. Silver Oak Securities Incorporated increased its position in UnitedHealth Group by 114.3% during the 4th quarter. Silver Oak Securities Incorporated now owns 2,336 shares of the healthcare conglomerate’s stock valued at $1,230,000 after buying an additional 1,246 shares in the last quarter. Fiduciary Group LLC boosted its stake in UnitedHealth Group by 5.4% in the 4th quarter. Fiduciary Group LLC now owns 3,674 shares of the healthcare conglomerate’s stock worth $1,934,000 after purchasing an additional 188 shares in the last quarter. Retirement Systems of Alabama increased its stake in UnitedHealth Group by 1.4% during the 4th quarter. Retirement Systems of Alabama now owns 458,403 shares of the healthcare conglomerate’s stock valued at $241,335,000 after purchasing an additional 6,156 shares in the last quarter. Meridian Wealth Partners LLC grew its holdings in shares of UnitedHealth Group by 9.2% during the fourth quarter. Meridian Wealth Partners LLC now owns 750 shares of the healthcare conglomerate’s stock valued at $395,000 after buying an additional 63 shares during the last quarter. Finally, Magnus Financial Group LLC raised its stake in UnitedHealth Group by 8.0% in the 4th quarter. Magnus Financial Group LLC now owns 4,486 shares of the healthcare conglomerate’s stock worth $2,362,000 after acquiring an additional 331 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH traded up $1.49 during mid-day trading on Friday, hitting $495.35. The stock had a trading volume of 2,727,016 shares, compared to its average volume of 5,623,667. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The stock has a market capitalization of $455.76 billion, a price-to-earnings ratio of 30.28, a PEG ratio of 1.43 and a beta of 0.54. The firm’s 50 day moving average is $485.84 and its 200 day moving average is $514.07. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period last year, the company posted $6.26 EPS. The business’s revenue was up 8.6% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.52%. UnitedHealth Group’s payout ratio is 45.97%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on UNH shares. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Bank of America reissued a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Oppenheimer reiterated an “outperform” rating and set a $610.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, January 17th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a report on Thursday, April 4th. Finally, Truist Financial reaffirmed a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.